Cas 676560-06-8,Carbamic acid, [1-(5-cyano-3-pyridinyl)-4-methyl-4-piperidinyl]-, phenylmethyl ester

676560-06-8

Post Buying Request

Basic information

Product Name: Carbamic acid, [1-(5-cyano-3-pyridinyl)-4-methyl-4-piperidinyl]-, phenylmethyl ester
Synonyms:
CAS NO:676560-06-8
Molecular Formula: C20H22N4O2
Molecular Weight: 350.42
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Carbamic acid, [1-(5-cyano-3-pyridinyl)-4-methyl-4-piperidinyl]-, phenylmethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Carbamic acid, [1-(5-cyano-3-pyridinyl)-4-methyl-4-piperidinyl]-, phenylmethyl ester(676560-06-8)
EPA Substance Registry System: Carbamic acid, [1-(5-cyano-3-pyridinyl)-4-methyl-4-piperidinyl]-, phenylmethyl ester(676560-06-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 676560-06-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

676560-06-8 Suppliers

Recommended suppliers

676560-06-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 676560-06-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,6,5,6 and 0 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 676560-06:
(8*6)+(7*7)+(6*6)+(5*5)+(4*6)+(3*0)+(2*0)+(1*6)=188
188 % 10 = 8
So 676560-06-8 is a valid CAS Registry Number.

676560-06-8Upstream product

676560-06-8Downstream Products

676560-06-8Relevant academic research and scientific papers

PHARMACEUTICAL COMPOSITIONS AS INHIBITORS OF DIPEPTIDYL PEPTIDASE-IV (DPP-IV)

-

Page 64-65, (2010/11/30)

The present invention relates to compounds which inhibit dipeptidyl peptidase IV (DPP-IV) and are useful for the prevention or treatment of diabetes, especially type II diabetes, as well as hyperglycemia, Syndrome X, hyperinsulinemia, obesity, atherosclerosis, and various immunomodulatory diseases.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 676560-06-8